Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
autologous bone marrow derived mesenchymal cells (1 trial)
Acute Lung Injury (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)